Co-Diagnostics Inc (CODX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,140 | -46,896 | -21,150 | -15,263 | -7,533 |
| Depreciation Amortization | 255 | 1,107 | 839 | 572 | 280 |
| Accounts receivable | 104 | -32 | 99 | -65 | -8 |
| Other Working Capital | 906 | -3,167 | -3,259 | -2,477 | -1,318 |
| Other Operating Activity | 28 | 19,851 | 534 | 200 | -167 |
| Operating Cash Flow | $-7,846 | $-29,137 | $-22,938 | $-17,033 | $-8,745 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -142 | -700 | -568 | -493 | -92 |
| Purchase Of Investment | N/A | -6,694 | -6,591 | -6,589 | -6,445 |
| Sale Of Investment | N/A | 33,667 | 33,762 | 31,510 | 13,894 |
| Investing Cash Flow | $-142 | $26,273 | $26,603 | $24,428 | $7,357 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4,335 | 11,812 | 4,842 | 784 | 355 |
| Financing Cash Flow | $4,335 | $11,812 | $4,842 | $784 | $355 |
| Beginning Cash Position | 11,885 | 2,937 | 2,937 | 2,937 | 2,937 |
| End Cash Position | 8,231 | 11,885 | 11,444 | 11,115 | 1,903 |
| Net Cash Flow | $-3,654 | $8,948 | $8,507 | $8,179 | $-1,034 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,846 | -29,137 | -22,938 | -17,033 | -8,745 |
| Capital Expenditure | -142 | -700 | -568 | -493 | -92 |
| Free Cash Flow | -7,988 | -29,837 | -23,506 | -17,526 | -8,837 |